Chronic Platelet Abnormalities in TIA Patients

  • M. Prencipe
  • C. Fieschi
  • M. P. Lazzaro
  • B. Orlandi
  • G. De Matteis
  • A. Carolei
Conference paper


Cerebral arterial thromboembolism is considered to be the most common pathogenic mechanism of ischemic stroke [1]. Since platelets play a major role in the formation and progression of arterial thrombosis, enhanced platelet activation may increase the risk of thromboembolic events [2]. While it is true that a thromboembolic stroke may well develop without systemic platelet abnormalities, permanently enhanced platelet activation may be a precipitating factor for thromboembolism in otherwise common diseases such as mitral valve prolapse (3, 4] and migraine [5].


Mitral Valve Prolapse Thromboembolic Stroke Platelet Abnormality Ischemic Cerebrovascular Disease Transient Ischemic Attack Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wolf PA, Dawber TR et al. (1977) Epidemiology of stroke. In: Thompson RA, Green JR (eds) Stroke. Advances in neurology 16. New York, Raven Press 5–19Google Scholar
  2. 2.
    Mustard JF et al. (1974) Recent status of research in the pathogenesis of thrombosis. Thromb Diathes Haemorah Suppl 59: 157–168Google Scholar
  3. 3.
    Scharf RE et al. (1982) Cerebral ischemia in young patients: Is it associated with mitral valve prolapse and abnormal platelet activity in vivo? Stroke 13: 454PubMedCrossRefGoogle Scholar
  4. 4.
    Peter N et al. (1981) Platelets, thromboembolism and mitral valve prolapse. Circulation 63, n 3: 552–559CrossRefGoogle Scholar
  5. 5.
    Kalendosky Z, Austin JH (1975) “Complicated migraine.” Its association with increased platelet aggregability and abnormal plasma coagulation factors. Headache 15: 18CrossRefGoogle Scholar
  6. 6.
    Wu KK, Hoak JC (1974) A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 2: 924–926PubMedCrossRefGoogle Scholar
  7. 7.
    De Marinis M, Fieschi C, Prencipe M et al. (1980) Circulating platelet aggregates: a chronic platelet activation in patients with transient ischaemic attacks. Italian J Neurol Sci 3: 163–170Google Scholar
  8. 8.
    Prencipe M et al. (1981) Increased circulating platelet aggregates in patients with transient ischemic attack. In: “Cerebral microcirculation and metabolism.” Cervos-Navarro, Fritschka E (eds). Raven Press, New YorkGoogle Scholar
  9. 9.
    Danta G (1970) Platelet adhesiveness in cerebrovascular disease. Atherosclerosis 11: 223PubMedCrossRefGoogle Scholar
  10. 10.
    Sharma SC et al. (1970) Platelet adhesiveness in young patients with ischaemic stroke. J Clin Pathol 30: 649.CrossRefGoogle Scholar
  11. 11.
    Chopra JS et al. (1980) A prospective study of lipid and coagulation parameters in stroke in young. Indian J Med Res 72: 731PubMedGoogle Scholar
  12. 12.
    Marra R et al. (1983) Evaluation of some coagulation parameters in cerebral ischemia. Acta Neurol Scand 67: 210PubMedCrossRefGoogle Scholar
  13. 13.
    Couch JR, Hassaneim RS (1976) Platelet aggregation, stroke, and transient ischemic attack in middle-aged and elderly patients. Neurology 26: 888PubMedGoogle Scholar
  14. 14.
    Lou HC et al. (1977) Platelet hyperaggregability in young patients with completed stroke. Acta Neurol Scand 56: 326PubMedCrossRefGoogle Scholar
  15. 15.
    Kobayashi J et al. (1976) Platelet aggregability measured by screen filtration pressure method in cerebrovascular disease. Stroke 7: 406PubMedCrossRefGoogle Scholar
  16. 16.
    Hansen PE et al. (1982) Platelet aggregation in focal cerebral ischemia- a clinical study. Acta Neurol Scand 65: 212PubMedCrossRefGoogle Scholar
  17. 17.
    Mettinger KL et al. (1979) Factor VIII related antigen, antithrombin III, spontaneous platelet aggregation and plasminogen activator in ischemic cerebrovascular disease. A study of stroke before 55. J Neurol Sci 41: 31–38PubMedCrossRefGoogle Scholar
  18. 18.
    Wahlberg TB et al. (1980) Blood coagulation studies in 45 patients in ischemic cerebrovascular disease and in 44 Pations with venous thromboembolic disease. Acta Med Scand 207: 385–390PubMedCrossRefGoogle Scholar
  19. 19.
    Yamazaki H, Takahashit T, Sano T (1975) Hyperaggregability of platelets in thromboembolic disorders. Thromb Diath Haemor 34: 94–105Google Scholar
  20. 20.
    Otsuki Y, Kondo T, Shio H et al. (1983) Platelet aggregability in cerebral thrombosis -analyzed for vessel stenosis. Stroke 14: 368–371PubMedCrossRefGoogle Scholar
  21. 21.
    Dougherty JH Jr, Levy DE, Weksler BB (1977) Platelet activation in acute cerebral ischemia. Serial measurements of platelet function in cerebrovascular disease. Lancet 1: 821–824PubMedCrossRefGoogle Scholar
  22. 22.
    Fisher M et al. (1982) Marker proteins of platelet activation in patients with cerebrovascular disease. Arch Neurol 39: 692PubMedGoogle Scholar
  23. 23.
    Hoogendijk E et al. (1979) Spontaneous platelet aggregation in cerebrovascular disease II. Thromb Haemost 41: 512PubMedGoogle Scholar
  24. 24.
    Levine PH et al. (1981) Human platelet factor 4: Preparation from outdated platelet concentrates and application in cerebral vascular disease. Am J Hematol 10: 375PubMedCrossRefGoogle Scholar
  25. 25.
    Lane DA et al. (1983) Activation of coagulation and fibrinolytic system following stroke. Br J Haematol 53: 655PubMedCrossRefGoogle Scholar
  26. 26.
    Wu KK, Hoak JC (1975) Increased platelet aggregates in patients with transient ischemic attacks. Stroke 6: 521PubMedCrossRefGoogle Scholar
  27. 27.
    Carolei A, Prencipe M et al. (1983) Platelet aggregates in angiographically proved carotid atherothrombotic disease. In: “International conference on platelet function and cardiovascular disease.” Strano A (ed): 191–194Google Scholar
  28. 28.
    Preston FE et al. (1978) Elevated P-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1: 238–240PubMedCrossRefGoogle Scholar
  29. 29.
    Colmar RW (1978) Platelet function in hyperbetalipoproteinemia. Thromb Hemostas 39: 284–293Google Scholar
  30. 30.
    Matsuda T et al. (1979) Comparison between plasma levels of β-thromboglobulin and platelet factor 4 in various diseases. Thromb Haemostas 42–288Google Scholar
  31. 31.
    Hughes A et al. (1979) Beta thromboglobulin and myocardial infarction. International Congress on Thrombosis and Haemostasis. London, Abstract: 850Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • M. Prencipe
    • 1
  • C. Fieschi
    • 2
  • M. P. Lazzaro
    • 1
  • B. Orlandi
    • 1
  • G. De Matteis
    • 1
  • A. Carolei
    • 2
  1. 1.Neurologic DepartmentUniversity of L’AquilaItaly
  2. 2.Department of Neurological SciencesUniversity of RomeItaly

Personalised recommendations